For years, gabapentinoids have enjoyed VIP status in multimodal pain protocols.
They’ve been the “responsible adult” in the room — non-opioid, neuropathic pain–targeting, and generally well-tolerated.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.

